P. Bedossa, Histological Assessment of NAFLD, Digestive Diseases and Sciences, vol.385, issue.5, pp.1348-55
DOI : 10.1007/s10620-016-4062-0

V. Paradis and P. Bedossa, Definition and natural history of metabolic steatosis : histology and cellular aspects. Diabetes Metab, pp.638-680, 2008.

N. Chalasani, Z. Younossi, J. Lavine, A. Diehl, E. Brunt et al., The diagnosis and management of non-­?alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, Liver Diseases, and American College of Gastroenterology. Gastroenterology, 2012.

K. Hitzenberger and M. Richter-­?quittner, Uber den Blutdruck bei Diabetes Mellitus, Wiener Arch Inn Med, vol.2, pp.461-467, 1921.

H. Haller and M. Hanefeld, Synoptische betrachtung metabolischer risikofactoren, Lipidstoffwechselstorungen. Iéna : Gustav Fischer verlag, pp.254-64

M. Hanefeld and W. Leonhardt, Das Metabolische Syndrom, Diabetologie und Stoffwechsel, vol.1, issue.5, pp.545-51, 1981.
DOI : 10.1055/s-2006-947258

G. Reaven and . Banting-lecture, Role of Insulin Resistance in Human Disease, Diabetes, vol.37, issue.12, pp.1595-607, 1988.
DOI : 10.2337/diab.37.12.1595

K. Alberti and P. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation, Diabetic Medicine, vol.15, issue.7, pp.539-53, 1998.
DOI : 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S

K. Alberti, P. Zimmet, and J. Shaw, The metabolic syndrome???a new worldwide definition, The Lancet, vol.366, issue.9491, pp.1059-62, 2005.
DOI : 10.1016/S0140-6736(05)67402-8

K. Alberti, R. Eckel, S. Grundy, P. Zimmet, J. Cleeman et al., Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, Circulation, vol.120, issue.16, pp.1640-1645, 2009.
DOI : 10.1161/CIRCULATIONAHA.109.192644

D. Lorenzo, A. , D. Gobbo, V. Premrov, M. Bigioni et al., Normal-­?weight obese syndrome : early inflammation ? Am J Clin Nutr, 2007.

L. Organisation-mondiale-de and . Santé, Obésité et surpoids Tiré de http://www.who.int/mediacentre/factsheets, p.79, 2016.

L. Organisation-mondiale-de and . Santé, Diabète. Tiré de http, 2016.

. Institut-national-de-veille-sanitaire, Données épidémiologiques du diabète Tiré de http Organisation mondiale de la Santé, 2015.

. Institut-national-de-veille-sanitaire, Données épidémiologiques du diabète Tiré de http://www.invs.sante.fr/Dossiers-­?thematiques/Maladies-­?chroniques-­?et-­? traumatismes, 2015.

G. Targher, G. Marchesini, and C. Byrne, Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?, Diabetes & Metabolism, vol.42, issue.3, pp.142-56, 2016.
DOI : 10.1016/j.diabet.2016.04.002

G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Borch-­?johnsen et al., Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women, Archives of Internal Medicine, vol.164, issue.10, pp.1066-76, 2004.
DOI : 10.1001/archinte.164.10.1066

E. Calle, C. Rodriguez, K. Walker-­?thurmond, and M. Thun, Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults, New England Journal of Medicine, vol.348, issue.17, pp.1625-1663, 2003.
DOI : 10.1056/NEJMoa021423

S. Bellentani, G. Saccoccio, F. Masutti, L. Crocè, G. Brandi et al., Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy, Annals of Internal Medicine, vol.132, issue.2, pp.112-119, 2000.
DOI : 10.7326/0003-4819-132-2-200001180-00004

J. Browning, L. Szczepaniak, R. Dobbins, P. Nuremberg, J. Horton et al., Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity, Hepatology, vol.83, issue.6, pp.1387-95, 2004.
DOI : 10.1002/hep.20466

T. Asselah, L. Rubbia-­?brandt, P. Marcellin, and F. Negro, STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?, Gut, vol.55, issue.1, pp.123-153, 2006.
DOI : 10.1136/gut.2005.069757

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856395

G. Farrell and C. Larter, Nonalcoholic fatty liver disease: From steatosis to cirrhosis, Hepatology, vol.99, issue.S1, pp.99-112, 2006.
DOI : 10.1002/hep.20973

P. Gholam, L. Flancbaum, J. Machan, D. Charney, and D. Kotler, Nonalcoholic Fatty Liver Disease in Severely Obese Subjects, The American Journal of Gastroenterology, vol.11, issue.2, pp.399-408, 2007.
DOI : 10.1007/BF00280883

. Trésor-public, Trésor-­?Eco n°179 : obésité : quelles conséquences pour l'économie et comment les limiter Tiré de, 2016.

D. Kleiner, E. Brunt, M. Van-natta, C. Behling, M. Contos et al., Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 2005.

P. Bedossa, C. Poitou, N. Veyrie, J. Bouillot, A. Basdevant et al., Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients, Hepatology, vol.100, issue.5, pp.1751-1760, 2012.
DOI : 10.1002/hep.25889

V. Paradis and P. Bedossa, Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabetes Metab, pp.638-680, 2008.

S. Mehta, E. Thomas, J. Bell, D. Johnston, and S. Taylor-­?robinson, Non-invasive means of measuring hepatic fat content, World Journal of Gastroenterology, vol.14, issue.22, pp.3476-83, 2008.
DOI : 10.3748/wjg.14.3476

S. Mazhar, M. Shiehmorteza, and C. Sirlin, Noninvasive Assessment of Hepatic Steatosis, Clinical Gastroenterology and Hepatology, vol.7, issue.2, pp.135-175, 2009.
DOI : 10.1016/j.cgh.2008.11.023

S. Saadeh, Z. Younossi, E. Remer, T. Gramlich, J. Ong et al., The utility of radiological imaging in nonalcoholic fatty liver disease, Gastroenterology, vol.123, issue.3, pp.745-50, 2002.
DOI : 10.1053/gast.2002.35354

E. Thomas, G. Hamilton, N. Patel, O. Dwyer, R. Doré et al., Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study, Gut, vol.54, issue.1, pp.122-129, 2005.
DOI : 10.1136/gut.2003.036566

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774370

T. Poynard, V. Ratziu, S. Naveau, D. Thabut, C. F. Messous et al., The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis, Comparative Hepatology, vol.4, issue.1, p.10, 2005.
DOI : 10.1186/1476-5926-4-10

T. Poynard, G. Lassailly, E. Diaz, K. Clement, R. Caïazzo et al., Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data, PLoS ONE, vol.49, issue.3, p.30325, 2012.
DOI : 10.1371/journal.pone.0030325.s005

G. Bedogni, S. Bellentani, L. Miglioli, F. Masutti, M. Passalacqua et al., The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population, BMC Gastroenterology, vol.23, issue.Suppl 2, p.33, 2006.
DOI : 10.1111/j.1365-2036.2006.02751.x

A. Kotronen, M. Peltonen, A. Hakkarainen, K. Sevastianova, R. Bergholm et al., Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors, Gastroenterology, vol.137, issue.3, pp.865-72, 2009.
DOI : 10.1053/j.gastro.2009.06.005

J. Lee, D. Kim, H. Kim, C. Lee, J. Yang et al., Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease, Digestive and Liver Disease, vol.42, issue.7, pp.503-511, 2010.
DOI : 10.1016/j.dld.2009.08.002

L. Fedchuk, F. Nascimbeni, R. Pais, C. F. Housset, C. Ratziu et al., Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, vol.51, issue.10, 2014.
DOI : 10.1111/apt.12963

J. Foucher, E. Chanteloup, J. Vergniol, L. Castera, L. Bail et al., Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study, Gut, vol.55, issue.3, pp.403-411, 2006.
DOI : 10.1136/gut.2005.069153

L. Castera, X. Forns, and A. Alberti, Non-invasive evaluation of liver fibrosis using transient elastography, Journal of Hepatology, vol.48, issue.5, pp.835-882, 2008.
DOI : 10.1016/j.jhep.2008.02.008

J. Foucher, L. Castéra, P. Bernard, X. Adhoute, D. Laharie et al., Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations, European Journal of Gastroenterology & Hepatology, vol.18, issue.4, pp.411-413, 2006.
DOI : 10.1097/00042737-200604000-00015

L. Castéra, J. Foucher, P. Bernard, F. Carvalho, D. Allaix et al., Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations, Hepatology, vol.46, issue.3, pp.828-863, 2010.
DOI : 10.1002/hep.23425

G. Wong, J. Vergniol, P. Lo, W. Wong, V. Foucher et al., Non-­?invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-­?offs of M probe to XL probe, Ann Hepatol, vol.12, issue.4, pp.570-80, 2013.

G. Wong, J. Vergniol, P. Lo, W. Wong, V. Foucher et al., Non-­?invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-­?offs of M probe to XL probe, Ann Hepatol, vol.12, issue.4, pp.570-80, 2013.

E. Durango, C. Dietrich, H. Seitz, C. Kunz, G. Pomier-­?layrargues et al., Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients, Hepat Med, vol.5, pp.43-52, 2013.

V. De-lédinghen, V. Wong, J. Vergniol, G. Wong, J. Foucher et al., Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan??, Journal of Hepatology, vol.56, issue.4, pp.833-842
DOI : 10.1016/j.jhep.2011.10.017

R. Myers, G. Pomier-­?layrargues, R. Kirsch, A. Pollett, A. Duarte-­?rojo et al., Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients, Hepatology, vol.53, issue.Suppl 1, pp.199-208, 2012.
DOI : 10.1002/hep.24624

V. De-lédinghen, J. Vergniol, J. Foucher, F. El-­?hajbi, W. Merrouche et al., Feasibility of liver transient elastography with FibroScan?? using a new probe for obese patients, Liver International, vol.49, issue.7, pp.1043-1051, 2010.
DOI : 10.1111/j.1478-3231.2010.02258.x

M. Sasso, M. Beaugrand, V. De-ledinghen, C. Douvin, P. Marcellin et al., Controlled Attenuation Parameter (CAP): A Novel VCTE??? Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes, Ultrasound in Medicine & Biology, vol.36, issue.11, pp.1825-1860, 2010.
DOI : 10.1016/j.ultrasmedbio.2010.07.005

M. Sasso, S. Audière, A. Kemgang, F. Gaouar, C. Corpechot et al., Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy, Ultrasound in Medicine & Biology, vol.42, issue.1, pp.92-103, 2016.
DOI : 10.1016/j.ultrasmedbio.2015.08.008

V. De-lédinghen, G. Wong, J. Vergniol, H. Chan, J. Hiriart et al., Controlled attenuation parameter for the diagnosis of steatosis in non-­?alcoholic fatty liver disease, J Gastroenterol Hepatol. 2016, vol.31, issue.4, pp.848-55

M. Ekstedt, L. Franzén, U. Mathiesen, L. Thorelius, M. Holmqvist et al., Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, vol.128, issue.4, pp.865-73, 2006.
DOI : 10.1002/hep.21327

S. Dam-­?larsen, M. Franzmann, I. Andersen, P. Christoffersen, L. Jensen et al., Long term prognosis of fatty liver: risk of chronic liver disease and death, Gut, vol.53, issue.5, pp.750-755, 2004.
DOI : 10.1136/gut.2003.019984

P. Angulo, D. Kleiner, S. Dam-­?larsen, L. Adams, E. Bjornsson et al., Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.149, issue.2, pp.389-97, 2015.
DOI : 10.1053/j.gastro.2015.04.043

M. Ekstedt, H. Hagström, P. Nasr, M. Fredrikson, P. Stål et al., Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up, Hepatology, vol.57, issue.5, pp.1547-54, 2015.
DOI : 10.1002/hep.27368

P. Angulo, E. Bugianesi, E. Bjornsson, P. Charatcharoenwitthaya, P. Mills et al., Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.145, issue.4, pp.782-791, 2013.
DOI : 10.1053/j.gastro.2013.06.057

J. Boursier, J. Vergniol, A. Guillet, J. Hiriart, A. Lannes et al., Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease, Journal of Hepatology, vol.65, issue.3, 2016.
DOI : 10.1016/j.jhep.2016.04.023

G. Calori, G. Lattuada, F. Ragogna, M. Garancini, P. Crosignani et al., Fatty liver index and mortality: The cremona study in the 15th year of follow-up, Hepatology, vol.34, issue.1, pp.145-52, 2011.
DOI : 10.1002/hep.24356

I. National-de-veille-sanitaire, Disparités régionales de la mortalité prématurée par maladie cardio-­?vasculaire en France, 2008.

H. Perazzo, M. Munteanu, Y. Ngo, P. Lebray, N. Seurat et al., Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia, Alimentary Pharmacology & Therapeutics, vol.12, issue.9, pp.1081-93, 2014.
DOI : 10.1111/apt.12946

G. Sebastiani, R. Alshaalan, P. Wong, M. Rubino, A. Salman et al., Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis, PLOS ONE, vol.28, issue.Suppl 2, p.128774, 2015.
DOI : 10.1371/journal.pone.0128774.t004

S. Treeprasertsuk, E. Björnsson, F. Enders, S. Suwanwalaikorn, and K. Lindor, NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients, World Journal of Gastroenterology, vol.19, issue.8, pp.1219-1248, 2013.
DOI : 10.3748/wjg.v19.i8.1219

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587478

J. Vergniol, J. Foucher, E. Terrebonne, P. Bernard, B. Le-bail et al., Noninvasive tests for fibrosis and liver stiffness predict 5-­?year outcomes of patients with chronic hepatitis C. Gastroenterology, pp.1970-1979, 1979.

V. De-lédinghen, J. Vergniol, C. Barthe, J. Foucher, F. Chermak et al., Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus, Alimentary Pharmacology & Therapeutics, vol.16, issue.10, pp.979-88, 2013.
DOI : 10.1111/apt.12307

R. Masuzaki, R. Tateishi, H. Yoshida, E. Goto, T. Sato et al., Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography, Hepatology, vol.19, issue.Suppl 1, pp.1954-61, 2009.
DOI : 10.1002/hep.22870

D. Franchis, R. Baveno, and V. Faculty, Expanding consensus in portal hypertension, Journal of Hepatology, vol.63, issue.3, pp.743-52, 2015.
DOI : 10.1016/j.jhep.2015.05.022

C. Chong, G. Wong, A. Chan, V. Wong, A. Fong et al., Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study, Journal of Gastroenterology and Hepatology, vol.56, issue.2, 2016.
DOI : 10.1111/jgh.13503